From February 18, 2024 to March 31, 2024, the company has repurchased 392,167 shares, representing 0.98% for CNY 11.7 million. With this, the company has completed the repurchase of 392,167 shares, representing 0.98% for CNY 11.7 million under the buyback announced on February 19, 2024.
Shanghai Rendu Biotechnology Co., Ltd.
Equities
688193
CNE1000059K5
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
31.55 CNY | -0.66% | +5.91% | -30.08% |
1st Jan change | Capi. | |
---|---|---|
-30.08% | 174M | |
-3.84% | 184B | |
-0.75% | 107B | |
-3.02% | 69.44B | |
+3.67% | 50.37B | |
+8.40% | 44.82B | |
+3.40% | 41.53B | |
+3.11% | 26.84B | |
+3.74% | 26.73B | |
+15.23% | 25.71B |
- Stock Market
- Equities
- 688193 Stock
- News Shanghai Rendu Biotechnology Co., Ltd.
- Tranche Update on Shanghai Rendu Biotechnology Co., Ltd.'s Equity Buyback Plan announced on February 19, 2024.